Skip navigation
Agenda

Rewriting the Playbook on Product-Specific Network Design, Contracting and Specialty Distribution Strategy

December 11-12, 2017
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE MONDAY, DECEMBER 11, 2017

7:30

Registration and Continental Breakfast

8:30

Chairman’s Welcome and Opening Remarks

Jeff Henderson
Vice President, Managed Markets
Intarcia Therapeutics, Inc.

Channel Trends, Market Economics and the
Evolving Regulatory Landscape

8:45

OPENING KEYNOTE Drug Channels Update — Things to Watch in 2018

Adam J. Fein, PhD
President, Pembroke Consulting, Inc.;
Author, Drug Channels

9:30

WORD ON WALL STREET Industry Analysts Sound Off on the Trends and Economic Factors Impacting the Bio/Pharmaceutical Sector

MODERATOR:

Adam J. Fein, PhD
President, Pembroke Consulting, Inc.;
Author, Drug Channels

PANELISTS:

Marc Appel
Vice President
Marathon Asset Management

George Hill
Managing Director
RBC Capital Markets

Robert Jones
Managing Director
Goldman Sachs

10:15

Networking and Refreshment Break

10:45

REGULATORY ROUND-UP State of the Industry — Politics Impacting Pharma

Gail Sibert
Director, Corporate Accounts
Ferring Pharmaceuticals, Inc.

Distribution Playbook Based on Product Class,
Reimbursement and Site of Care

11:30

LUMINARY ADDRESS Fragmentation and Customization Comes to Pharmaceutical Channels

William Roth
Founding Partner
Blue Fin Group

12:30

Networking Luncheon

PRODUCT-SPECIFIC STRATEGIC SHOWCASE Navigate and Optimize Distribution Strategy Based on
Product Type and Reimbursement

In a complex and ever-evolving ecosystem, industry is tasked with trying to figure out the best strategy for distribution. What makes this so challenging is that different distribution constructs are needed for different types of products. For example, do you have to go product by product? Do you base the strategy off of the therapeutic area? If you launch an orally-administered oncology drug, does that have any bearing if you launch an infusible? When putting together the product distribution models it is critical that manufacturers are taking into account all of the key factors that impact the bottom line. So, what’s important when it comes to distribution right now? And, how do you keep the channel philosophy similar, but still allow for tailored characteristics of the drug? During this Showcase, dive deep into the different product types and the corresponding factors you need to consider for your channel strategy.

1:45

Brand and Generics

MODERATOR:

Tom Doyle
Executive Vice President, Commercial Solutions
H. D. Smith Specialty Solutions

PANELISTS:

Scott Parker
Director, Trade
Mallinckrodt

Jeff Henderson
Vice President, Managed Markets
Intarcia Therapeutics, Inc.

Gail Sibert
Director, Corporate Accounts
Ferring Pharmaceuticals, Inc.

2:30

Specialty

How does a pharmacy benefit change your thoughts on distribution strategy relative to medical benefit? During session, explore the optimal distribution strategies based on the reimbursement pathway.

I. Pharmacy Benefit Reimbursement

II. Medical Benefit Reimbursement

MODERATOR:

Nick Calla
Vice President, Industry Relations
Cardinal Health Specialty Pharmacy

PANELISTS:

Spencer Miller
Director, Trade and Distribution
AMAG Pharmaceuticals

Chris Boneham
Executive Director, Managed Markets
Aralez Pharmaceuticals US Inc.

John Campo
Senior Director, Trade and Distribution
BTG

3:15

Networking and Refreshment Break

3:45

Biosimilars

James Van Lieshout
Former Vice President, Trade and Industry Relations
Apobiologix, a division of ApoPharma USA

4:30

Orphan

Scot Buchanan
Vice President, Biotech and Specialty Services
Therigy

Rich Gourash
Vice President, Specialty Outcomes
Therigy

5:15

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO TUESDAY, DECEMBER 12, 2017

8:00

Continental Breakfast

8:30

CHOOSE FROM THREE TAILORED TRACKS (I-III)

I Specialty Distribution and Channel Optimization

8:20

Track Chair Welcome

Jeff Henderson
Vice President, Managed Markets
Intarcia Therapeutics, Inc.

8:30

Establishing Partnerships with IDNs to Affect the Patient Journey
and Outcomes

Jerry Buller
Director, Specialty Pharmacy Services
Vanderbilt University Medical Center

9:30

PAYER DYNAMICS AND DRUG UTILIZATION MANAGEMENT Payer Approach and Decision-Making Journey for Specialty Drugs

Tracey McGuire, RPh, MSA
Specialty Services Director
MedImpact Healthcare Systems, Inc.

10:15

Networking and Refreshment Break

10:45

Customizing Your Distribution/Commercialization Strategy for Cell Therapy & Immuno-Oncology

Layne Martin
Vice President/General Manager, Specialty Distribution Solutions
McKesson Specialty Health

11:30

Key Considerations for Hub and Pharmacy Alignment

Tony Lanzone
Managing Director
inVentiv Health Consulting

12:15

Networking Luncheon

1:15

Streamlining Coordination of Specialty Care for Better Patient Outcomes

Glenn Boyer
Sales Executive
CoverMyMeds

II Serialization and Traceability

8:20

Track Chair Welcome

Daniel Matlis
President
Axendia

8:30

SPOTLIGHT Update on the European and US Drug Supply Chain Security Act (DSCSA) and the Drug Tracing Pilot Programs

Bill Fletcher
Managing Partner
Pharma Logic Solutions, LLC

9:30

Push to Drive Business Value from Serialization

Bill Henderson
Executive Vice President, Commercial Development
ValueCentric

10:15

Networking and Refreshment Break

10:45

Best Practices for Compliant Implementation of Serialization, Including US DSCSA, EU and Other Countries

Bill Fletcher
Managing Partner
Pharma Logic Solutions, LLC

11:30

IT THINK TANK Proven Strategies to Achieve End-to-End Traceability

FACILITATOR:

Daniel Matlis
President
Axendia

12:15

Networking Luncheon

1:15

Spotlight on Small Data —
Leveraging Specialty Product Data to Drive Positive Outcomes

Jon Hamrick
Chief Strategy Officer
Therigy

III Specialty Product Data Strategies

8:20

Track Chair Welcome

Jane Urban
Lead, Specialty Decision Support and Reporting
Takeda Pharmaceuticals U.S.A., Inc.

8:30

Specialty Trends and Implications for Data Strategy

Jason Drenning, PhD
Director, Internal Operations, Sonexus™ Access and Patient Support
Cardinal Health Specialty Solutions

9:30

Building a Specialty Data Culture to Optimize Operations

Jane Urban
Lead, Specialty Decision Support and Reporting
Takeda Pharmaceuticals U.S.A., Inc.

10:15

Networking and Refreshment Break

10:45

Strategies for a Differentiated Specialty Patient Experience

Josh Halpern
Co-Founder, Executive Vice President
IntegriChain

11:30

Inside Look at Next- Generation Specialty Data Aggregation
and Analytics

John Giannouris
Vice President, Specialty Pharma Services
ValueCentric

12:15

Networking Luncheon

1:15

Spotlight on Small Data —
Leveraging Specialty Product Data to Drive Positive Outcomes

Jon Hamrick
Chief Strategy Officer
Therigy

2:00

Close of Tracks and Brief Transition Break

Attendees Convene for General Closing Sessions

2:15

Specialty Data Discovery Dive —
Finding the Missing Link in Your Products Value Story

Marc Duey
President & CEO
Prometrics

3:00

VISIONARY PANEL The Future of Specialty Product Data —
Industry Expectations, Shared Opportunities and Challenges

In this closing session, the speaking faculty share insights on the path forward toward interoperability.

John Giannouris
Vice President, Specialty Pharma Services
ValueCentric

Jane Urban
Lead, Specialty Decision Support and Reporting
Takeda Pharmaceuticals U.S.A., Inc.

Ryan Cronin
Channel Performance and Analytics
Lilly USA, LLC

Patrick R. Coyle
Vice President, Financial Planning and Analysis
Insmed, Inc.

4:00

Close of Conference

Agenda

Want more agenda details? Download the brochure.
Want more agenda details? Download the brochure.

DAY ONE MONDAY, DECEMBER 11, 2017

7:30

Registration and Continental Breakfast

8:30

Chairman’s Welcome and Opening Remarks

Jeff Henderson
Vice President, Managed Markets
Intarcia Therapeutics, Inc.

Channel Trends, Market Economics and the
Evolving Regulatory Landscape

8:45

OPENING KEYNOTE Drug Channels Update — Things to Watch in 2018

Adam J. Fein, PhD
President, Pembroke Consulting, Inc.;
Author, Drug Channels

9:30

WORD ON WALL STREET Industry Analysts Sound Off on the Trends and Economic Factors Impacting the Bio/Pharmaceutical Sector

MODERATOR:

Adam J. Fein, PhD
President, Pembroke Consulting, Inc.;
Author, Drug Channels

PANELISTS:

Marc Appel
Vice President
Marathon Asset Management

George Hill
Managing Director
RBC Capital Markets

Robert Jones
Managing Director
Goldman Sachs

10:15

Networking and Refreshment Break

10:45

REGULATORY ROUND-UP State of the Industry — Politics Impacting Pharma

Gail Sibert
Director, Corporate Accounts
Ferring Pharmaceuticals, Inc.

Distribution Playbook Based on Product Class,
Reimbursement and Site of Care

11:30

LUMINARY ADDRESS Fragmentation and Customization Comes to Pharmaceutical Channels

William Roth
Founding Partner
Blue Fin Group

12:30

Networking Luncheon

PRODUCT-SPECIFIC STRATEGIC SHOWCASE Navigate and Optimize Distribution Strategy Based on
Product Type and Reimbursement

In a complex and ever-evolving ecosystem, industry is tasked with trying to figure out the best strategy for distribution. What makes this so challenging is that different distribution constructs are needed for different types of products. For example, do you have to go product by product? Do you base the strategy off of the therapeutic area? If you launch an orally-administered oncology drug, does that have any bearing if you launch an infusible? When putting together the product distribution models it is critical that manufacturers are taking into account all of the key factors that impact the bottom line. So, what’s important when it comes to distribution right now? And, how do you keep the channel philosophy similar, but still allow for tailored characteristics of the drug? During this Showcase, dive deep into the different product types and the corresponding factors you need to consider for your channel strategy.

1:45

Brand and Generics

MODERATOR:

Tom Doyle
Executive Vice President, Commercial Solutions
H. D. Smith Specialty Solutions

PANELISTS:

Scott Parker
Director, Trade
Mallinckrodt

Jeff Henderson
Vice President, Managed Markets
Intarcia Therapeutics, Inc.

Gail Sibert
Director, Corporate Accounts
Ferring Pharmaceuticals, Inc.

2:30

Specialty

How does a pharmacy benefit change your thoughts on distribution strategy relative to medical benefit? During session, explore the optimal distribution strategies based on the reimbursement pathway.

I. Pharmacy Benefit Reimbursement

II. Medical Benefit Reimbursement

MODERATOR:

Nick Calla
Vice President, Industry Relations
Cardinal Health Specialty Pharmacy

PANELISTS:

Spencer Miller
Director, Trade and Distribution
AMAG Pharmaceuticals

Chris Boneham
Executive Director, Managed Markets
Aralez Pharmaceuticals US Inc.

John Campo
Senior Director, Trade and Distribution
BTG

3:15

Networking and Refreshment Break

3:45

Biosimilars

James Van Lieshout
Former Vice President, Trade and Industry Relations
Apobiologix, a division of ApoPharma USA

4:30

Orphan

Scot Buchanan
Vice President, Biotech and Specialty Services
Therigy

Rich Gourash
Vice President, Specialty Outcomes
Therigy

5:15

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO TUESDAY, DECEMBER 12, 2017

8:00

Continental Breakfast

8:30

CHOOSE FROM THREE TAILORED TRACKS (I-III)

I Specialty Distribution and Channel Optimization

8:20

Track Chair Welcome

Jeff Henderson
Vice President, Managed Markets
Intarcia Therapeutics, Inc.

8:30

Establishing Partnerships with IDNs to Affect the Patient Journey
and Outcomes

Jerry Buller
Director, Specialty Pharmacy Services
Vanderbilt University Medical Center

9:30

PAYER DYNAMICS AND DRUG UTILIZATION MANAGEMENT Payer Approach and Decision-Making Journey for Specialty Drugs

Tracey McGuire, RPh, MSA
Specialty Services Director
MedImpact Healthcare Systems, Inc.

10:15

Networking and Refreshment Break

10:45

Customizing Your Distribution/Commercialization Strategy for Cell Therapy & Immuno-Oncology

Layne Martin
Vice President/General Manager, Specialty Distribution Solutions
McKesson Specialty Health

11:30

Key Considerations for Hub and Pharmacy Alignment

Tony Lanzone
Managing Director
inVentiv Health Consulting

12:15

Networking Luncheon

1:15

Streamlining Coordination of Specialty Care for Better Patient Outcomes

Glenn Boyer
Sales Executive
CoverMyMeds

II Serialization and Traceability

8:20

Track Chair Welcome

Daniel Matlis
President
Axendia

8:30

SPOTLIGHT Update on the European and US Drug Supply Chain Security Act (DSCSA) and the Drug Tracing Pilot Programs

Bill Fletcher
Managing Partner
Pharma Logic Solutions, LLC

9:30

Push to Drive Business Value from Serialization

Bill Henderson
Executive Vice President, Commercial Development
ValueCentric

10:15

Networking and Refreshment Break

10:45

Best Practices for Compliant Implementation of Serialization, Including US DSCSA, EU and Other Countries

Bill Fletcher
Managing Partner
Pharma Logic Solutions, LLC

11:30

IT THINK TANK Proven Strategies to Achieve End-to-End Traceability

FACILITATOR:

Daniel Matlis
President
Axendia

12:15

Networking Luncheon

1:15

Spotlight on Small Data —
Leveraging Specialty Product Data to Drive Positive Outcomes

Jon Hamrick
Chief Strategy Officer
Therigy

III Specialty Product Data Strategies

8:20

Track Chair Welcome

Jane Urban
Lead, Specialty Decision Support and Reporting
Takeda Pharmaceuticals U.S.A., Inc.

8:30

Specialty Trends and Implications for Data Strategy

Jason Drenning, PhD
Director, Internal Operations, Sonexus™ Access and Patient Support
Cardinal Health Specialty Solutions

9:30

Building a Specialty Data Culture to Optimize Operations

Jane Urban
Lead, Specialty Decision Support and Reporting
Takeda Pharmaceuticals U.S.A., Inc.

10:15

Networking and Refreshment Break

10:45

Strategies for a Differentiated Specialty Patient Experience

Josh Halpern
Co-Founder, Executive Vice President
IntegriChain

11:30

Inside Look at Next- Generation Specialty Data Aggregation
and Analytics

John Giannouris
Vice President, Specialty Pharma Services
ValueCentric

12:15

Networking Luncheon

1:15

Spotlight on Small Data —
Leveraging Specialty Product Data to Drive Positive Outcomes

Jon Hamrick
Chief Strategy Officer
Therigy

2:00

Close of Tracks and Brief Transition Break

Attendees Convene for General Closing Sessions

2:15

Specialty Data Discovery Dive —
Finding the Missing Link in Your Products Value Story

Marc Duey
President & CEO
Prometrics

3:00

VISIONARY PANEL The Future of Specialty Product Data —
Industry Expectations, Shared Opportunities and Challenges

In this closing session, the speaking faculty share insights on the path forward toward interoperability.

John Giannouris
Vice President, Specialty Pharma Services
ValueCentric

Jane Urban
Lead, Specialty Decision Support and Reporting
Takeda Pharmaceuticals U.S.A., Inc.

Ryan Cronin
Channel Performance and Analytics
Lilly USA, LLC

Patrick R. Coyle
Vice President, Financial Planning and Analysis
Insmed, Inc.

4:00

Close of Conference